Influence of transfusion-transmitted virus infection on the clinical features and response to interferon therapy in Japanese patients with chronic hepatitis C

Journal of Viral Hepatitis

Volumn 6, Issue 6, 1999, Pages 463-469

  Hagiwara, H ^a   Hayashi, N ^b   Mita, E ^b   Oshita, M ^c   Kobayashi, I ^a   Iio, S ^a   Hiramatsu, N ^b   Sasaki, Y ^b   Kasahara, A ^d   Kakinuma, K ^e   Yamauchi, T ^e   Fusamoto, H ^a  

^a Higashiosaka City General Hospital   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c OSAKA POLICE HOSPITAL   (Japan)

^d OSAKA UNIVERSITY HOSPITAL   (Japan)

^e SRL INC   (Japan)

Author keywords

Biochemical response; Co infection; Fibrosis; Viral interference; Virological response

Indexed keywords

INTERFERON;

ADULT; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CHRONIC HEPATITIS; CLINICAL FEATURE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEPATITIS C; HEPATITIS G VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROPREVALENCE; VIRUS GENOME; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; ANTIVIRAL AGENTS; DNA VIRUS INFECTIONS; DNA VIRUSES; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; JAPAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0032704097     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1999.00183.x     Document Type: Article

References (33)

1. Simons JN, Leary TP, Dawson GJ et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564-569.
2. Linnen J, Wages J Jr, Zhang-Kech ZY et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-508.
3. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-1132.
4. Heringlake S, Osterkamp S, Trautwein C et al. Association between fulminant hepatic failure and a strain of GBV-C. Lancet 1996; 348: 1626-1629.
5. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 1996; 334: 195-196.
6. Masuko K, Mitsui T, Iwano K et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-1490.
7. Berenguer M, Terrault NA, Piatak M et al. Hepatitis G virus infection in patients with hepatitis C virus infection undergoing liver transplantation. Gastroenterology 1996; 111: 1569-1575.
8. Bralet MP, Roudot-Thoraval F, Pawlotsky JM et al. Histopathologic impact of GB virus C infection on chronic hepatitis C. Gastroenterology 1997; 112: 188-192.
9. Francesconi R, Giostra F, Ballardini G et al. Clinical implications of GBV-C/HGV infection in patients with 'HCV-related' chronic hepatitis. J Hepatol 1997; 26: 1165-1172.
10. Manolakopoulos S, Morris A, Davies S, Brown D, Hajat S, Dusheiko G. Influence of GB virus C viraemia on the clinical, virological and histological features of early hepatitis C-related hepatic disease. J Hepatol 1998; 28: 173-178.
11. Oshita M, Hayashi N, Mita E et al. GBV-C/HGV infection in chronic hepatitis C patients: its effect on clinical features and interferon therapy. J Med Virol 1998; 55: 98-102.
12. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyazawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997; 241: 92-97.
13. Okamoto H, Nishizawa T, Kato N et al. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 1998; 10: 1-16.
14. Simmonds P, Davidson F, Lycett C et al. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet 1998; 352: 191-195.
15. Naoumov NV, Petrova EP, Thomas MG, Williams R. Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet 1998; 352: 195-197.
16. Charlton M, Adjei P, Poterucha J et al. TT-virus infection in north American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology 1998; 28: 839-842.
17. Fong TL, DiBisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991; 14: 64-67.
18. Pontisso P, Ruvoletto MG, Fatovich G et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993; 105: 1529-1533.
19. Feray C, Gigou M, Samuel D et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993; 104: 549-555.
20. Chu CM, Sheen IS, Liaw YF. The role of hepatitis C virus in fulminant viral hepatitis in an endemic area of hepatitis A and B. Gastroenterology 1994; 107: 189-195.
21. Weltman MD, Brotodihardjo A, Crewe EB et al. Coinfection with hepatitis B and C, or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hep 1995; 2: 39-45.
22. Yuki N, Hayashi N, Kasahara A et al. Hepatitis B virus markers and antibodies to hepatitis C virus in Japanese patients with hepatocellular carcinoma. Dig Dis Sci 1992; 37: 65-72.
23. Benvegnu L, Fottovich G, Noventa F et al. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma. A prospective study. Cancer 1994; 74: 2442-2448.
24. Ohkawa K, Hayashi N, Yuki N et al. Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients. J Hepatol 1994; 21: 509-514.
25. Ohkawa K, Hayashi N, Yuki N et al. Long-term follow-up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses. J Med Virol 1995; 46: 258-264.
26. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995; 22: 1101-1108.
27. Hagiwara H, Hayashi N, Mita E et al. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology 1993; 17: 545-550.
28. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
29. Lau JYN, Davis GL, Kniffen J et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501-1504.
30. Mita E, Hayashi N, Hagiwara H et al. Predicting Interferon therapy efficacy from hepatitis C virus genotype and RNA titer. Dig Dis Sci 1994; 39: 977-982.
31. Simmonds P, Alberti A, Alter HJ et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321-1324.
32. Hagiwara H, Hayashi N, Mita E et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 1993; 104: 877-883.
33. Desmet VJ, Gerber M. Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.